Trial intelligence / Profile preview

Ketamine for Postoperative Cognitive Dysfunction in Elderly Orthopedic Patients

NCT02220400Unknown

Sponsor
Renji Hospital
Start
Sep 2014
Primary completion
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of ketamine in Post-operative cognitive dysfunction (POCD), sponsored by Renji Hospital. Primary endpoints: Short-term cognitive changes after surgery at 7 days and Long-term cognitive changes after surgery at 2 months. Status: unknown.

02

Drugs

ketamine
03

Conditions

Post-operative cognitive dysfunction (POCD)

Beyond the preview

Go deeper on NCT02220400.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02220400.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call